Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

KINI: a one compartment intravenous pharmacokinetic analysis program

K R Franck1, J S Bertino

  • 1Department of Pharmacy Services, Mary Imogene Bassett Hospital, Cooperstown, NY 13326.

Computer Methods and Programs in Biomedicine
|March 1, 1994
PubMed
Summary

KINI software enables individualized pharmacokinetic analysis for any drug using the Sawchuk-Zaske method. This PC-based package supports adult and pediatric patient data, aiding clinical decision-making.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of intravenous flumazenil on oral midazolam pharmacokinetics and pharmacodynamics for use as a cytochrome P450 3A probe.

International journal of clinical pharmacology and therapeutics·2009
Same author

Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis.

Clinical pharmacology and therapeutics·2007
Same author

Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adults.

Antimicrobial agents and chemotherapy·2006
Same author

Integrating fluoroquinolones into the hospital formulary.

Pharmacotherapy·2001
Same author

Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe.

Journal of clinical pharmacology·2001
Same author

Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping.

Pharmacogenetics·2001

Area of Science:

  • Pharmacokinetics
  • Clinical Pharmacology
  • Computational Biology

Background:

  • Accurate pharmacokinetic parameter determination is crucial for optimizing drug therapy.
  • Individualized dosing requires robust analytical methods.
  • Existing software may lack flexibility for diverse patient populations and data formats.

Purpose of the Study:

  • To introduce KINI, a microcomputer PC-based software package.
  • To enable the determination of one-compartment pharmacokinetic parameters using the Sawchuk-Zaske method.
  • To facilitate individualized pharmacokinetic analyses for clinical application.

Main Methods:

  • Utilizes the Sawchuk-Zaske method for pharmacokinetic analysis.
  • Designed for microcomputer PC platforms.

Related Experiment Videos

  • Offers both long and abbreviated data entry formats.
  • Supports analysis for both adult and pediatric patients.

    • Main Results:

    • KINI successfully determines one-compartment pharmacokinetic parameters.
    • Individualized pharmacokinetic analyses can be performed efficiently.
    • The software accommodates varied data input and patient demographics.
    • Generates compatible data files for clinical documentation (WordPerfect 5.0/5.1).

    Conclusions:

    • KINI provides a valuable tool for individualized pharmacokinetic analysis.
    • The software enhances the application of the Sawchuk-Zaske method in clinical settings.
    • Facilitates personalized drug therapy management through accessible computational methods.